| In search of p53 target genes for the therapeutic manipulation of cancer. | |
| | |
MedLine Citation:
|
PMID: 16566288 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
As a tumor suppressor protein, p53 plays a crucial role in cancer development. Direct associations between p53, apoptosis and drug response suggest that targeting genes/gene products downstream of p53 may have clinical benefits. The completion of the human genome project and the availability of microarray technology have led to new ways in which to define the global regulatory network of p53 and to search for oncogenes in the p53 pathway. A crucial step toward antitumor drug discovery is the mapping of p53 transcriptomes onto cancer phenomes. In this review, recent developments in the genome-wide search of p53 target genes are discussed, along with current efforts in high-throughput antitumor target discovery in the p53 pathway and recent progress in the pharmacological modulation of targets downstream of p53 for effective cancer therapy. |
| | |
Authors:
|
Suxing Liu; Cynthia Seidel-Dugan |
Related Documents
:
|
15153938 - Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian ... 11390388 - Cyclopentenone prostaglandins of the j series inhibit the ubiquitin isopeptidase activi... 10930048 - Apoptosis, pcna, and p53 in fundulus grandis fish liver after in vivo exposure to n-met... 17640378 - Mif coordinates the cell cycle with dna damage checkpoints. lessons from knockout mouse... 11121138 - Distinct effects of cd30 and fas signaling in cutaneous anaplastic lymphomas: a possibl... 15108268 - Liver transplantation for neuroendocrine tumors: progress and uncertainty. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in drug discovery & development Volume: 9 ISSN: 1367-6733 ISO Abbreviation: Curr Opin Drug Discov Devel Publication Date: 2006 Mar |
Date Detail:
|
Created Date: 2006-03-28 Completed Date: 2006-04-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100887519 Medline TA: Curr Opin Drug Discov Devel Country: England |
Other Details:
|
Languages: eng Pagination: 176-83 Citation Subset: IM |
Affiliation:
|
Biological Research-Oncology, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA. suxing.liu@spcorp.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Design Gene Targeting* Gene Therapy* Genes, p53 / drug effects* Humans Neoplasms / therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Embryonic stem cells: a great hope for a new era of medicine.
Next Document: Bispecific antibodies for dual-modality cancer therapy: killing two signaling cascades with one ston...